Clinical Trial Update: Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Antrrix Probiotics for improving recurrent respiratory tract infections in infants and young children; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• Antrrix Probiotics (Probiotic formulation)

Snippet

Sponsor: Min-Tze LIONG | Conditions: Recurrent Respiratory Tract Infections | Phase 2 | Status: RECRUITING